Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis
详细信息 查看全文
- 作者：Matthew L Stoll (1)
Ranjit Kumar (2)
Casey D Morrow (3)
Elliot J Lefkowitz (4)
Xiangqin Cui (5)
Anna Genin (1)
Randy Q Cron (1)
Charles O Elson (6) - 刊名：Arthritis Research & Therapy
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：16
- 期：6
- 全文大小：1,181 KB
- 参考文献：1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data Workgroup: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. / Part I. Arthritis Rheum 2008, 58:15鈥?5. CrossRef
2. Reveille JD: The genetic basis of spondyloarthritis. / Ann Rheum Dis 2011, 70:i44鈥搃50. CrossRef
3. Reveille JD: Genetics of spondyloarthritis鈥揵eyond the MHC. / Nat Rev Rheumatol 2012, 8:296鈥?04. CrossRef
4. Fantini MC, Pallone F, Monteleone G: Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. / World J Gastroenterol 2009, 15:2472鈥?478. CrossRef
5. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. / J Exp Med 1994, 180:2359鈥?364. CrossRef
6. Metzker ML: Sequencing technologies - the next generation. / Nat Rev Genet 2010, 11:31鈥?6. CrossRef
7. Cheng J, Palva AM, de Vos WM, Satokari R: Contribution of the intestinal microbiota to human health: from birth to 100聽years of age. / Curr Top Microbiol Immunol 2013, 358:323鈥?46.
8. Stebbings S, Munro K, Simon MA, Tannock G, Highton J, Harmsen H, Welling G, Seksik P, Dore J, Grame G, Tilsala-Timisjarvi A: Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. / Rheumatology (Oxford) 2002, 41:1395鈥?401. CrossRef
9. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas E, Elson CO, Hershberg RM: Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn鈥檚 disease. / Gastroenterology 2005, 128:2020鈥?028. CrossRef
10. Wallis D, Asaduzzaman A, Weisman M, Haroon N, Anton A, McGovern D, Targan S, Inman R: Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. / Arthritis Res Ther 2013, 15:R166. CrossRef
11. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM: Bacterial flagellin is a dominant antigen in Crohn disease. / J Clin Invest 2004, 113:1296鈥?306. CrossRef
12. Stebbings SM, Taylor C, Tannock GW, Baird MA, Highton J: The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. / J Rheumatol 2009, 36:797鈥?00. CrossRef
13. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. / J Rheumatol 2004, 31:390鈥?92.
14. McGhee JL, Burks FN, Sheckels JL, Jarvis JN: Identifying children with chronic arthritis based on chief complaints: absence of predictive value for musculoskeletal pain as an indicator of rheumatic disease in children. / Pediatrics 2002, 110:354鈥?59. CrossRef
15. Cary SG, Blair EB: New Transport Medium for Shipment of Clinical Specimens. I. Fecal Specimens. / J Bacteriol 1964, 88:96鈥?8.
16. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R: Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. / Proc Natl Acad Sci U S A 2011, 108:4516鈥?522. CrossRef
17. Gordon A, Hannon GJ: / 鈥淔ASTX-Toolkit鈥? FASTQ/A short-reads pre-processing tools (unpublished). 2013. Available from: http://hannonlab.cshl.edu/fastx_toolkit/.
18. Edgar RC: Search and clustering orders of magnitude faster than BLAST. / Bioinformatics 2010, 26:2460鈥?461. CrossRef
19. Wang Q, Garrity GM, Tiedje JM, Cole JR: Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. / Appl Environ Microbiol 2007, 73:5261鈥?267. CrossRef
20. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL: Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. / Appl Environ Microbiol 2006, 72:5069鈥?072. CrossRef
21. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R: PyNAST: a flexible tool for aligning sequences to a template alignment. / Bioinformatics 2010, 26:266鈥?67. CrossRef
22. Faith DP, Baker AM: Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges. / Evol Bioinform Online 2006, 2:121鈥?28.
23. Lozupone C, Knight R: UniFrac: a new phylogenetic method for comparing microbial communities. / Appl Environ Microbiol 2005, 71:8228鈥?235. CrossRef
24. Suzuki R, Shimodaira H: Pvclust: an R package for assessing the uncertainty in hierarchical clustering. / Bioinformatics 2006, 22:1540鈥?542. CrossRef
25. Johnson CL, Versalovic J: The human microbiome and its potential importance to pediatrics. / Pediatrics 2012, 129:950鈥?60. CrossRef
26. De Cruz P, Prideaux L, Wagner J, Ng SC, McSweeney C, Kirkwood C, Morrison M, Kamm MA: Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. / Inflamm Bowel Dis 2012, 18:372鈥?90. CrossRef
27. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. / Gastroenterology 2004, 126:1620鈥?633. CrossRef
28. Elson CO, Cong Y: Host-microbiota interactions in inflammatory bowel disease. / Gut Microbes 2012, 3:332鈥?44. CrossRef
29. Rosenbaum JT, Davey MP: Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. / Arthritis Rheum 2011, 63:3195鈥?198. CrossRef
30. Thorkildsen LT, Nwosu FC, Avershina E, Ricanek P, Perminow G, Brackmann S, Vatn MH, Rudi K: Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. / Gastroenterol Res Pract 2013, 2013:636785. CrossRef
31. Wang W, Chen L, Zhou R, Wang X, Song L, Huang S, Wang G, Xia B: Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. / J Clin Microbiol 2014, 52:398鈥?06. CrossRef
32. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. / Proc Natl Acad Sci U S A 2007, 104:13780鈥?3785. CrossRef
33. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blotti猫re HM, Dor茅 J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. / Proc Natl Acad Sci U S A 2008, 105:16731鈥?6736. CrossRef
34. Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ: Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. / Appl Environ Microbiol 2003, 69:4320鈥?324. CrossRef
35. Segain JP, Raingeard de la Bl茅ti猫re D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blotti猫re HM, Galmiche JP: Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn鈥檚 disease. / Gut 2000, 47:397鈥?03. CrossRef
36. Louis P, Young P, Holtrop G, Flint HJ: Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. / Environ Microbiol 2010, 12:304鈥?14. CrossRef
37. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. / Elife 2013, 2:e01202. CrossRef
38. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E: Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. / Inflamm Bowel Dis 2011, 17:179鈥?84. CrossRef
39. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. / Science 2011, 332:974鈥?77. CrossRef
40. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J Jr: Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. / Emerg Infect Dis 2000, 6:171鈥?74. CrossRef
41. Sinkorova Z, Capkova J, Niederlova J, Stepankova R, Sinkora J: Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. / Hum Immunol 2008, 69:845鈥?50. CrossRef
42. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB: Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. / J Clin Invest 1996, 98:945鈥?53. CrossRef
43. Derrien M, Vaughan EE, Plugge CM, de Vos WM: Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. / Int J Syst Evol Microbiol 2004, 54:1469鈥?476. CrossRef
44. Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM: The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. / Appl Environ Microbiol 2008, 74:1646鈥?648. CrossRef
45. Ganesh BP, Klopfleisch R, Loh G, Blaut M: Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. / PLoS One 2013, 8:e74963. CrossRef
46. Fite A, Macfarlane S, Furrie E, Bahrami B, Cummings JH, Steinke DT, MacFarlane GT: Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration. / J Clin Microbiol 2013, 51:849鈥?56. CrossRef
47. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P: The immune geography of IgA induction and function. / Mucosal Immunol 2008, 1:11鈥?2. CrossRef
48. Gutzeit C, Magri G, Cerutti A: Intestinal IgA production and its role in host-microbe interaction. / Immunol Rev 2014, 260:76鈥?5. CrossRef
49. Liu LM, MacPherson GG: Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. / Immunology 1995, 85:88鈥?3.
50. Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP: FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA. / J Immunol 2007, 178:3973鈥?982. CrossRef
51. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C: Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. / Genome Biol 2012, 13:R79. CrossRef
52. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. / Nature 2006, 444:1027鈥?031. CrossRef - 作者单位：Matthew L Stoll (1)
Ranjit Kumar (2)
Casey D Morrow (3)
Elliot J Lefkowitz (4)
Xiangqin Cui (5)
Anna Genin (1)
Randy Q Cron (1)
Charles O Elson (6)
1. Department of Pediatric Rheumatology, University of Alabama at Birmingham, CPP N 210M, 1600 7th Avenue South, Birmingham, AL, 35233, USA
2. Center for Clinical and Translational Sciences, University of Alabama at Birmingham, CPP N 210M, 1720 2nd Avenue South, Birmingham, AL, 35294, USA
3. Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, CPP N 210M, 1720 2nd Avenue South, Birmingham, AL, 35294, USA
4. Department of Microbiology, University of Alabama at Birmingham, CPP N 210M, 1720 2nd Avenue South, Birmingham, AL, 35294, USA
5. Department of Biostatistics, University of Alabama at Birmingham, CPP N 210M, 1720 2nd Avenue South, Birmingham, AL, 35294, USA
6. Department of Medicine 鈥?Gastroenterology, University of Alabama at Birmingham, CPP N 210M, 1720 2nd Avenue South, Birmingham, AL, 35294, USA - ISSN：1478-6354
文摘
Introduction Prior studies have established altered microbiota and immunologic reactivity to enteric commensal organisms in inflammatory bowel disease (IBD). Since intestinal inflammation is present in a subset of patients with both pediatric and adult spondyloarthritis (SpA), we hypothesized that SpA patients may also have altered microbiota and immune responsiveness to enteric organisms. Methods Stool and blood specimens were collected from children with enthesitis-related arthritis (ERA) and non-inflammatory controls. DNA purified from stool was subject to PCR amplification and sequencing of the variable IV region from the 16S rDNA gene. IgA and IgG Enzyme-linked Immunosorbent Assays (ELISAs) were performed on select species of bacteria in most subjects. Results Twenty-five children with ERA and 13 controls were included. The ERA patients had less Faecalibacterium prausnitzii (3.8% versus 10%, P = 0.008) and lachnospiraceae family (12 versus 7.0%, P = 0.020), a statistically significant increase in bifidobacterium (1.8% versus 0%, P = 0.032) and a non-statistically significant increase in Bacteroides (21% versus 11%, P = 0.150). Akkermansia muciniphila was abundant (>2%) in 7/27 ERA patients but none of the controls (P = 0.072.) Cluster analysis revealed two clusters of ERA patients: Cluster one (n = 8) was characterized by high levels of Bacteroides genus, while a second (n = 15) cluster had similar levels as the controls. Seven of 17 (41%) of the ERA subjects in Cluster 2 compared to 0/8 of the subjects in Cluster 1 had abundant Akkermansia muciniphila (P = 0.057). Serum IgA and IgG antibody levels against F. prausnitzii and B. fragilis were similar between patients and controls, whereas the two groups showed divergent responses when the fecal relative abundances of F. prausnitzii and Bacteroides were compared individually against IgA antibody levels recognizing F. prausnitzii and B. fragilis, respectively. Conclusion The abundance of F. prausnitzii in the stool among patients with ERA is reduced compared to controls, and Bacteroides and A. muciniphila are identified as associative agents in subsets of ERA patients. Differences in the humoral responses to these bacteria may contribute to disease.